EU Pharmaceutical Strategy Roadmap: high time to improve patient access to medicines and to apply the lessons from Covid19

COVID-19 a lightning rod for major overhaul of EU… 9 July 2020 Urgent call for a structured industry-EU dialogue on reform The…
European Parliament report calls for increased use of… 24 November 2021 Open
Smart reform of EU pharma and IP legislation key to boosting… 28 June 2022 Generic and biosimilar medicines lower healthcare treatment costs dramatically and…
Christoph Stoller and Adrian van den Hoven interviewed by… 17 July 2020 In the wake of the publication of Medicines for Europe’s Lessons…